An Outstanding Weight Loss Combo
Prof. Dr. Mohamed Elhashemy
November 27, 2008
Obese people want the quickest way to lose weight. Most of them seek out weight-loss tips from celebrity magazines and the latest fad diets.
It is settled that FDA only approved two drugs up till now which are Xenical & Meridia. The first drug acts on the gut while the second acts on satiety center of the brain. Bariatric surgery is also effective but of course dangerous.
As I am very interested in the field of stomach satiety - which I think it will be The Coming Revolution in Obesity Management - I developed a new scientific diet plan strategy that leads to early stomach satiety. My strategy is based on reaching this early stomach satiety through achieving two components:
1. Component I: Boosting the activity of Elhashemy's Stomach Satiety Spot "ESSS", through hybrid exercises consisting of: observing 3-D animation that mimics grinded peanuts hitting stomach satiety spot, while eating in the meantime 3 of such peanuts. This will boost ESSS psychologically through persuasion and neurologically through vagal nerve terminals. 3-D virtual experience through repeated exposures several times weekly would allow obese to sense feeling of early satiety for long. My patients´ results are outstanding since they ate less and shed weight more than any other diet ever known. Technology presents many opportunities to improve the way we live and learn.
2. Component II: Blocking Ghrelin hormone, through eating Luqaimat regularly; every 2-3 hours. This will lower hunger hormone blood level before it rises, as I discussed before in many articles on my webpage on American Chronicle.
I think that summation of component I plus component II will lead to early satiety, hence great body weight loss. In June 27th, 2008; I postulated my theory of Elhashemy´s Stomach Satiety Spot "ESSS". It is the first theory to postulate that there must be a spot in the stomach that when being hit will lead to non-expansion of the stomach musculature, hence less accommodation for food and as a result to lower caloric intake leading to progressive weight loss.
I postulated that gastric hunger and brain craving integrate together to direct person's eating behavior to gain extra pleasure through eating extra amount of food. Of course this leads to gaining extra weight. By repeated stimulation of Elhashemy´s Stomach Satiety Spot "ESSS", the brain satiety center will respond early to the effect of any small-sized meals (Luqaimat).
The stomach mucosa is richly innervated by afferent vagal fibers which are mostly condensed at the fundus. The intramuscular afferents are gastric tension receptors. The function of the highly arborizing intramyenteric vagal afferent endings is not known up till now. I think that they are responsible for satiety sensations, which leads to blocking the gastric relaxation, hence reducing a person's ability and desire to gorge on.
Nowadays, I am studying the effects of activation of ESSS on 20 of my morbidly obese patients who are under standard Luqaimat diet (components I plus II) in comparison to 40 patients of similar BMI under same diet but without activation of such spot (Component II alone). After passage of 8 weeks, I found a great difference between both groups amounting to 25% more weight loss in favor of first group (20 pounds & 26.5 pounds weight loss, respectively).
I expect that the new combo of Luqaimat diet in addition to boosting ESSS could result in more than 70 pounds weight-loss in 6 months for those patients with BMI 40 or more. These expected results are outstanding as they are very close to those of bariatric surgeries.
It is settled that FDA only approved two drugs up till now which are Xenical & Meridia. The first drug acts on the gut while the second acts on satiety center of the brain. Bariatric surgery is also effective but of course dangerous.
As I am very interested in the field of stomach satiety - which I think it will be The Coming Revolution in Obesity Management - I developed a new scientific diet plan strategy that leads to early stomach satiety. My strategy is based on reaching this early stomach satiety through achieving two components:
1. Component I: Boosting the activity of Elhashemy's Stomach Satiety Spot "ESSS", through hybrid exercises consisting of: observing 3-D animation that mimics grinded peanuts hitting stomach satiety spot, while eating in the meantime 3 of such peanuts. This will boost ESSS psychologically through persuasion and neurologically through vagal nerve terminals. 3-D virtual experience through repeated exposures several times weekly would allow obese to sense feeling of early satiety for long. My patients´ results are outstanding since they ate less and shed weight more than any other diet ever known. Technology presents many opportunities to improve the way we live and learn.
2. Component II: Blocking Ghrelin hormone, through eating Luqaimat regularly; every 2-3 hours. This will lower hunger hormone blood level before it rises, as I discussed before in many articles on my webpage on American Chronicle.
I think that summation of component I plus component II will lead to early satiety, hence great body weight loss. In June 27th, 2008; I postulated my theory of Elhashemy´s Stomach Satiety Spot "ESSS". It is the first theory to postulate that there must be a spot in the stomach that when being hit will lead to non-expansion of the stomach musculature, hence less accommodation for food and as a result to lower caloric intake leading to progressive weight loss.
I postulated that gastric hunger and brain craving integrate together to direct person's eating behavior to gain extra pleasure through eating extra amount of food. Of course this leads to gaining extra weight. By repeated stimulation of Elhashemy´s Stomach Satiety Spot "ESSS", the brain satiety center will respond early to the effect of any small-sized meals (Luqaimat).
The stomach mucosa is richly innervated by afferent vagal fibers which are mostly condensed at the fundus. The intramuscular afferents are gastric tension receptors. The function of the highly arborizing intramyenteric vagal afferent endings is not known up till now. I think that they are responsible for satiety sensations, which leads to blocking the gastric relaxation, hence reducing a person's ability and desire to gorge on.
Nowadays, I am studying the effects of activation of ESSS on 20 of my morbidly obese patients who are under standard Luqaimat diet (components I plus II) in comparison to 40 patients of similar BMI under same diet but without activation of such spot (Component II alone). After passage of 8 weeks, I found a great difference between both groups amounting to 25% more weight loss in favor of first group (20 pounds & 26.5 pounds weight loss, respectively).
I expect that the new combo of Luqaimat diet in addition to boosting ESSS could result in more than 70 pounds weight-loss in 6 months for those patients with BMI 40 or more. These expected results are outstanding as they are very close to those of bariatric surgeries.